In an amicus brief submitted to the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trade Office, AAM urged the PTAB to reject Allergan’s effort to avoid the PTAB review of the validity of its patents by renting the sovereign immunity of the St. Regis Mohawk Tribe. Brand name drug companies who abuse the patent system harm patients by forcing them to pay monopoly prices far longer than they should.
